Refine
Language
- English (133)
Has Fulltext
- yes (133)
Is part of the Bibliography
- no (133)
Keywords
- Hadron-Hadron Scattering (7)
- Collective Flow (3)
- Heavy Ion Experiments (2)
- Jets (2)
- Boosted Jets (1)
- Collective Flow, (1)
- Data sharing (1)
- Guiana Shield (1)
- Hard Scattering (1)
- Heavy Quark Production (1)
Institute
The production cross section of inclusive isolated photons has been measured by the ALICE experiment at the CERN LHC in pp collisions at centre-of-momentum energy of s√=13 TeV collected during the LHC Run 2 data-taking period. The measurement is performed by combining the measurements of the electromagnetic calorimeter EMCal and the central tracking detectors ITS and TPC, covering a pseudorapidity range of |ηγ|<0.67 and a transverse momentum range of 7<pγT<200 GeV/c. The result extends to lower pγT and xγT=2pγT/s√ ranges, the lowest xγT of any isolated photon measurements to date, extending significantly those measured by the ATLAS and CMS experiments towards lower pγT at the same collision energy with a small overlap between the measurements. The measurement is compared with next-to-leading order perturbative QCD calculations and the results from the ATLAS and CMS experiments as well as with measurements at other collision energies. The measurement and theory prediction are in agreement with each other within the experimental and theoretical uncertainties.
Clinically relevant immune responses against Cytomegalovirus : implications for precision medicine
(2019)
Immune responses to human cytomegalovirus (CMV) can be used to assess immune fitness in an individual. Further to its clinical significance in posttransplantation settings, emerging clinical and translational studies provide examples of immune correlates of protection pertaining to anti-CMV immune responses in the context of cancer or infectious diseases, e.g., tuberculosis. In this viewpoint, we provide a brief overview about CMV-directed immune reactivity and immune fitness in a clinical context and incorporate some of our own findings obtained from peripheral blood or tumour-infiltrating lymphocytes (TIL) from patients with advanced cancer. Observations in patients with solid cancers whose lesions contain both CMV and tumour antigen-specific T-cell subsets are highlighted, due to a possible CMV-associated "bystander" effect in amplifying local inflammation and subsequent tumour rejection. The role of tumour-associated antibodies recognising diverse CMV-derived epitopes is also discussed in light of anti-cancer immune responses. We discuss here the use of anti-CMV immune responses as a theranostic tool—combining immunodiagnostics with a personalised therapeutic potential—to improve treatment outcomes in oncological indications.
We herein present the first annotated anuran checklist for the Brazilian state of Amapá, eastern Amazonia, based on a thorough literature review. We recorded the occurrence of 111 species belonging to 13 anuran families distributed across 48 localities throughout Amapá, within two biomes. Among these species, 62.5% occur exclusively in the Tropical Moist Broadleaf Forest biome, ~8% occur exclusively in the Tropical Savanna biome, and ~29% occur in both. Two species were considered endemic to Amapá and were registered only in the central portion of the state. Regarding the conservation status, only one species (Dendropsophus amicorum) is classified as threatened, assigned to the “critically endangered” category. The other species are categorized as either “least concern” or “data deficient” (85 and 8, respectively), whereas 21 are not evaluated. The current annotated list contributes to the incipient knowledge on anuran species richness in Amapá and, despite the research regarding anuran taxonomy has considerably progressed over the past 20 years, there is still much to do. Our data highlight the need for trained taxonomists to develop research in the state.